亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會(huì)員登錄|免費(fèi)注冊(cè)|忘記密碼|管理入口 返回主站||保存桌面|手機(jī)瀏覽|聯(lián)系方式|購(gòu)物車
企業(yè)會(huì)員第1年

深圳市思科達(dá)生物技術(shù)有限公司  

專業(yè)經(jīng)營(yíng)化學(xué)標(biāo)準(zhǔn)品，對(duì)照品
搜索
新聞中心
  • 暫無(wú)新聞
產(chǎn)品分類
  • 暫無(wú)分類
聯(lián)系方式
  • 聯(lián)系人：楊森
  • 電話：0755-89218244
  • 郵件：lq@szskerd.com
  • 傳真：0755-28984072
  • QQ：793285927
站內(nèi)搜索
 
榮譽(yù)資質(zhì)
  • 暫未上傳
友情鏈接
  • 暫無(wú)鏈接
福沙吡坦
單價(jià) 面議對(duì)比
詢價(jià) 暫無(wú)
發(fā)貨 廣東深圳市付款后3天內(nèi)
品牌 深圳市思科達(dá)生物技術(shù)有限公司
過(guò)期 長(zhǎng)期有效
更新 2014-12-02 13:09
 
詳細(xì)信息
 產(chǎn)品名稱：福沙吡坦 雜質(zhì) 標(biāo)準(zhǔn)品 對(duì)照品 265121-04-8

產(chǎn)品關(guān)鍵詞：福沙吡坦 雜質(zhì) 標(biāo)準(zhǔn)品 對(duì)照品 265121-04-8

福沙吡坦二甲葡胺                                Fosaprepitant                              100mg

SSR-福沙匹坦                                       SSR-Fosaprepitant                      10mg/25mg/50mg

RRR-福沙匹坦                                      RRR-Fosaprepitant                     10mg/25mg/50mg

SSS-福沙匹坦                                        SSS-Fosaprepitant                      10mg/25mg/50mg

RSR-福沙匹坦                                       RSR-Fosaprepitant                     10mg/25mg/50mg

SRS-福沙匹坦                                       SRS-Fosaprepitant                      10mg/25mg/50mg

SRR-福沙匹坦                                       SRR-Fosaprepitant                     10mg/25mg/50mg

RSS-福沙匹坦                                       RSS-Fosaprepitant                      10mg/25mg/50mg
©2025 深圳市思科達(dá)生物技術(shù)有限公司 版權(quán)所有   技術(shù)支持：化工網(wǎng)   訪問(wèn)量:12469  
 
主站蜘蛛池模板： | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |